| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/02/2005 | US6924290 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 08/02/2005 | US6924284 PARP inhibitors |
| 08/02/2005 | US6924281 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 08/02/2005 | US6924277 Central nervous system disorders; antidepressants; bipolar disorders; rhematic diseases |
| 08/02/2005 | US6924276 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors |
| 08/02/2005 | US6924266 NTP-peptides and method for removal of tumors |
| 08/02/2005 | US6924117 Human RRP sequences and methods of use |
| 08/02/2005 | US6923993 Process of isolating extract from the Euphorbia obesa plant and methods for using the same |
| 08/02/2005 | US6923988 Solid carrier includes a hydrophililc surfactant and a drug |
| 08/02/2005 | US6923958 For immunizing a mammal against cancer cells that present a carcinoembryonic antigen (CEA) |
| 08/02/2005 | CA2267904C Fusogenic liposome composition and method |
| 08/02/2005 | CA2170020C Retroviral protease inhibiting compounds |
| 08/02/2005 | CA2118121C Methods and compositions for the treatment of diseases with interferon while reducing side effects |
| 08/02/2005 | CA2078539C Process for producing humanized chimera antibody |
| 07/28/2005 | WO2005068491A1 Antitumoral and antiviral peptides |
| 07/28/2005 | WO2005068469A1 Multi-nuclear metal complexes partially encapsulated by cucurbit[7-12]urils |
| 07/28/2005 | WO2005068429A1 Derivatives of pyridine and quinoline |
| 07/28/2005 | WO2005067981A1 Gene therapy for tumor using minus-strand rna virus vector encoding immunostimulating cytokine |
| 07/28/2005 | WO2005067914A1 Preventive or ameliorating agent for liver disease involving hepatopathy |
| 07/28/2005 | WO2005033102A3 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 07/28/2005 | WO2005027936A3 Pharmaceutical compositions and therapeutical treatment with oligo-beta-(1, 3)-glucans |
| 07/28/2005 | WO2005027710A3 Methods for identifying subjects at risk of melanoma and treatments thereof |
| 07/28/2005 | WO2005026337A3 Adenoviral vector for infecting cells deficient in a car receptor |
| 07/28/2005 | WO2004087734A3 Stq-peptides |
| 07/28/2005 | WO2004033620A3 Methods and compositions for therapeutic use of rna interference |
| 07/28/2005 | US20050166274 Compositions and methods for the diagnosis and treatment of tumor |
| 07/28/2005 | US20050165227 Antiproliferative agents; gene overexpression |
| 07/28/2005 | US20050165219 Related to the thymic stromal cotransporter subfamily; can be used as models for the development of and aid in the identification of therapeutic proteins that modulate transporter activity |
| 07/28/2005 | US20050165118 Hypotensive agents; antiinflammatory agents; gastrointestinal disorders; autoimmune disease; 4-phenyl pinene derivatives |
| 07/28/2005 | US20050165106 Preferentially inhibit the inducible isoform of nitric oxide synthase |
| 07/28/2005 | US20050165103 for enhancing the endogenous production of interleukin-10 (IL-10) and suppressing the production of interleukin-2 in mammalian cells or tissues; inhibiting the proliferation of stimulated peripheral mononuclear cells |
| 07/28/2005 | US20050165093 Supermolecular carboplatinum derivatives, their preparation and pharmaceutical composition containing tem as active ingredient and applications of the compositions |
| 07/28/2005 | US20050165087 Nf-kb inhibitors |
| 07/28/2005 | US20050165086 Aminothiophene inhibitors of NF- kappa B inhibitors for treatment of diseases such as cancer or aids |
| 07/28/2005 | US20050165081 for the reduction of the rate of a new contralateral primary tumour |
| 07/28/2005 | US20050165071 administering two or more timed doses of epothilone b; treating a drug resistant tumor |
| 07/28/2005 | US20050165066 Antiproliferative agents |
| 07/28/2005 | US20050165064 Novel thiol derivative, process for producing the same and use thereof |
| 07/28/2005 | US20050165063 Amine compounds and use thereof |
| 07/28/2005 | US20050165051 Taxanes having a C7 carbonate substituent |
| 07/28/2005 | US20050165039 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 07/28/2005 | US20050165036 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 07/28/2005 | US20050165017 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050165009 Remedy for glioblastoma |
| 07/28/2005 | US20050164995 Method of locking 1alpha-OH of vitamin D compounds in axial orientation |
| 07/28/2005 | US20050164976 Combination of a cdk inhibitor and 5-fu for the tratment of cancer |
| 07/28/2005 | US20050164965 DNA or RNA having a modified backbone or base and a section that hybridizes to an EphrinB2 or EphB4 transcript causing gene expression inhibition; antineoplastic and antiproliferative agents can be synergistically administered with a second agent |
| 07/28/2005 | US20050164936 Antiinflammatory and antitumor agents; human T-cell leukemia/lymphoma virus and lymphadenopathy associated virus treatment; angiogenic- or hematopoiesis-related diseases; medical diagnosis |
| 07/28/2005 | US20050164926 Novel recombinant anticoagulant proteins |
| 07/28/2005 | US20050164906 Inhibitors of the Mitogen Activated Protein Kinases (MAPKs) pathway activated by Ras/Raf complex using GILZ (glucocorticoid-Induced Leucine Zipper) protein related compounds as inhibitors of Raf/Ras-mediated signal transduction; anticarcinogenic agents |
| 07/28/2005 | US20050164352 Immunoglobulin interleukin fusion for activating lymphoid precursor cells; treatment and prevention of infection |
| 07/28/2005 | US20050164313 Methods and compositions for the detection of cervical cancer |
| 07/28/2005 | US20050164298 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor(ghs) |
| 07/28/2005 | US20050164278 Breast cancer specific genes (BSG) and diagnosing/preventing cell proliferative disorders; immunotherapy; paramagnetic imaging |
| 07/28/2005 | US20050164267 Using caudal-1 gene (CDX-1) as diagnostic indicator of stomach or esophageal cancer; immunodiagnostics |
| 07/28/2005 | US20050164263 identification of amino acid sequences and proteins related to MAP/ERK subfamily; gene chip; transgenic nonhuman animal; nucleic acid vector; expression in larynx epithelium, Wilms' tumors of the kidney, pancreas adenocarcinomas, fetal brain, and hippocampus; models for human therapeutic targets |
| 07/28/2005 | US20050164234 Antisense therapy; gene expression inhibition |
| 07/28/2005 | US20050164201 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses therof |
| 07/28/2005 | US20050164194 Growth regulating proteins |
| 07/28/2005 | US20050164185 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta |
| 07/28/2005 | US20050163876 Cancer treatment using natural plant products or essential oils or components from some pistacia species |
| 07/28/2005 | US20050163835 Gefitinib or salt with and a water-soluble cellulose ether or an ester of a water-soluble cellulose ether; increased absorption and/or bioavailability and may reduce inter-patient variability; prevents precipitation in higher pH upper GI |
| 07/28/2005 | US20050163807 complex comprising the attenuated verotoxin or its A subunit with a ligand that specifically and selectively binds to a cancer cell, and an anticancer agent comprising the complex as an active ingredient |
| 07/28/2005 | US20050163801 Method of inducing apoptosis and compositions therefor |
| 07/28/2005 | US20050163793 Methods for recovering peptides from stress protein-peptide complexes |
| 07/28/2005 | US20050163786 Compounds and methods for modulating adhesion molecule function |
| 07/28/2005 | US20050163785 affect cell growth by blocking progression of the cell cycle in G2/M and their use in therapy of cancers which express the antigen |
| 07/28/2005 | US20050163778 Extracorporeal photopheresis in combination with anti-TNF treatment |
| 07/28/2005 | US20050163770 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 07/28/2005 | US20050163751 Synergistic mixture with compounds such as interferon, paclitaxel or P-16; side effect reduction |
| 07/28/2005 | US20050163710 Gastrin receptor-avid peptide conjugates |
| 07/28/2005 | US20050163707 Radio labelled monoclonal antibody human milk fat globule1, binds selectively to polymorphic epithelial mucin; Taxotere chemotherapeutic agent; administered in combination |
| 07/28/2005 | DE10359384A1 Verwendung eines Extraktes von Aloysia triphylla als Matrixprotektor Use of an extract of Aloysia triphylla as a matrix protector |
| 07/28/2005 | DE10206849A1 Phenalenon-Derivate, Verfahren zur Herstellung und Verwendung derselben Phenalenone derivatives, to processes for preparing and using the same |
| 07/28/2005 | CA2554001A1 Epitope/peptide recognized by hla-a2402-restricted ep-cam-specific ctl and use of the same |
| 07/28/2005 | CA2553953A1 Therapeutic use of quinonoid derivatives of cannabinoids |
| 07/28/2005 | CA2553377A1 Gene therapy for tumors using minus-strand rna viral vectors encoding immunostimaulatory cytokines |
| 07/28/2005 | CA2552965A1 Carboxamide derivative and use thereof |
| 07/28/2005 | CA2552826A1 2-amino-o4-substituted pteridines and their use as inactivators of o6-alkylguanine-dna alkyltransferase |
| 07/28/2005 | CA2552550A1 Piperidine derivatives as gcs inhibitors |
| 07/28/2005 | CA2552471A1 Combination of crf antagonists and 5-ht 1b receptor antagonists |
| 07/28/2005 | CA2552027A1 Multi-nuclear metal complexes partially encapsulated by cucurbit[7-12]urils |
| 07/28/2005 | CA2551948A1 Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives as igf-ir inhibitors |
| 07/28/2005 | CA2547703A1 Bicyclic pyrazolo-fused compounds as protein kinase modulators |
| 07/28/2005 | CA2547080A1 Heterocyclic protein kinase inhibitors and uses thereof |
| 07/28/2005 | CA2540272A1 Preventive or ameliorating agent for liver diseases associated with hepatopathy |
| 07/27/2005 | EP1557670A1 REGULATION OF INTERACTION BETWEEN RAPL AND Rap1 |
| 07/27/2005 | EP1557428A1 Antibodies against a human stromal derived factor (SDF) and pharmaceutical composition containing them |
| 07/27/2005 | EP1557424A1 Bi-cyclic nucleoside, nucleotide and oligonucleoide analogues |
| 07/27/2005 | EP1557418A1 Novel quinoxaline derivatives |
| 07/27/2005 | EP1557415A1 Heterocyclic compounds and antitumor drugs containing the same as the active ingredient |
| 07/27/2005 | EP1557411A1 N-phenyl-(2r,5s)dimethylpiperadine derivative |
| 07/27/2005 | EP1557172A1 Method and composition for regulating the activity of regulatory t cells |
| 07/27/2005 | EP1557168A2 Biarylurea Derivatives |
| 07/27/2005 | EP1556705A2 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 14 (gpr14) |
| 07/27/2005 | EP1556410A2 Peptide fragments of the harp factor inhibiting angiogenesis |
| 07/27/2005 | EP1556401A2 22 human secreted proteins |
| 07/27/2005 | EP1556398A1 Novel cytarabine monophosphate prodrugs |
| 07/27/2005 | EP1556393A2 Novel cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs |